Cite
HARVARD Citation
Papp, K. et al. (n.d.). Tofacitinib, an oral Janus kinase inhibitor, for the treatment of chronic plaque psoriasis: results from two randomized, placebo‐controlled, phase III trials. British journal of dermatology. pp. 949-961. [Online].